Literature DB >> 16220006

Exposure to endotoxins during sensitization prevents further endotoxin-induced exacerbation of airway inflammation in a mouse model of allergic asthma.

Carine Delayre-Orthez1, Julien Becker, Frédéric de Blay, Nelly Frossard, Françoise Pons.   

Abstract

BACKGROUND: We have shown previously that lipopolysaccharides (LPS) inhibited airway inflammation in allergen-sensitized and challenged mice when administered during sensitization, while exacerbating the inflammation when given upon challenge. We have here investigated the effect of LPS administered during both sensitization and challenge on airway inflammation, as well as on the profile of the T-helper (Th) response to allergen.
METHODS: Mice were sensitized and challenged with ovalbumin (OVA), in the presence or absence of effective doses of LPS, namely 1 mug during sensitization and 1 ng during challenge. Inflammation was assessed by measuring cell counts and cytokine levels in bronchoalveolar lavage fluid (BALF). The profile of the Th response was determined by quantifying OVA-specific IgE and IgG2a in serum and Th1/Th2 cytokines in the culture medium of splenocytes and in BALF.
RESULTS: Allergen-induced airway eosinophilia was increased in mice exposed to LPS during challenge only when compared with controls, whereas it was similarly reduced in animals exposed during sensitization only and during both sensitization and challenge. Mice exposed to LPS during sensitization only or during both sensitization and challenge also displayed a decrease in IgE and an increase in IgG2a, suggesting a switch in the immune response toward the Th1 profile. This was confirmed by quantification of Th1/Th2 cytokines in culture medium of splenocytes and in BALF.
CONCLUSIONS: Our data demonstrate that exposure to endotoxins during sensitization prevents allergen-induced airway inflammation, as well as its exacerbation triggered by further exposure to endotoxins during challenge, while switching the immune response to allergen from a Th2 to a Th1 profile. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220006     DOI: 10.1159/000088867

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  13 in total

1.  Effect of low doses of lipopolysaccharide prior to ozone exposure on bronchoalveolar lavage: Differences between wild type and surfactant protein A-deficient mice.

Authors:  Rizwanul Haque; Todd M Umstead; Kwangmi Ahn; David S Phelps; Joanna Floros
Journal:  Pneumon       Date:  2009

2.  Lung myeloid-derived suppressor cells and regulation of inflammation.

Authors:  Prabir Ray; Meenakshi Arora; Stephanie L Poe; Anuradha Ray
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 3.  LPS-induced CD11b+Gr1(int)F4/80+ regulatory myeloid cells suppress allergen-induced airway inflammation.

Authors:  Meenakshi Arora; Stephanie L Poe; Anuradha Ray; Prabir Ray
Journal:  Int Immunopharmacol       Date:  2011-02-12       Impact factor: 4.932

4.  Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Authors:  Lien Van Hoecke; Emma Richelle Job; Xavier Saelens; Kenny Roose
Journal:  J Vis Exp       Date:  2017-05-04       Impact factor: 1.355

5.  Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain.

Authors:  Leonardo H Tonelli; Andrew Holmes; Teodor T Postolache
Journal:  Neuropsychopharmacology       Date:  2007-06-27       Impact factor: 7.853

6.  Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses.

Authors:  K Kulhankova; C L S George; J N Kline; J M Snyder; M Darling; E H Field; P S Thorne
Journal:  Clin Exp Allergy       Date:  2009-04-28       Impact factor: 5.018

7.  Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease.

Authors:  Ama-Tawiah Essilfie; Jodie L Simpson; Jay C Horvat; Julie A Preston; Margaret L Dunkley; Paul S Foster; Peter G Gibson; Philip M Hansbro
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

8.  Intranasal LPS-mediated Parkinson's model challenges the pathogenesis of nasal cavity and environmental toxins.

Authors:  Qing He; Wenbo Yu; Jianjun Wu; Chan Chen; Zhiyin Lou; Qiong Zhang; Jian Zhao; Jian Wang; Baoguo Xiao
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study.

Authors:  Tillie-Louise Hackett; Rebecca Holloway; Stephen T Holgate; Jane A Warner
Journal:  Respir Res       Date:  2008-05-29

Review 10.  Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation.

Authors:  Anuradha Ray; Krishnendu Chakraborty; Prabir Ray
Journal:  Front Cell Infect Microbiol       Date:  2013-09-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.